Details
| Stereochemistry | EPIMERIC |
| Molecular Formula | C19H22O2.C7H17NO5 |
| Molecular Weight | 477.5904 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CC(C(O)=O)C1=CC=C(C2CCCCC2)C3=C1C=CC=C3
InChI
InChIKey=SGAJMCQBAWHKKC-WZTVWXICSA-N
InChI=1S/C19H22O2.C7H17NO5/c1-13(19(20)21)15-11-12-16(14-7-3-2-4-8-14)18-10-6-5-9-17(15)18;1-8-2-4(10)6(12)7(13)5(11)3-9/h5-6,9-14H,2-4,7-8H2,1H3,(H,20,21);4-13H,2-3H2,1H3/t;4-,5+,6+,7+/m.0/s1
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: O19183 Gene ID: 791253.0 Gene Symbol: PTGS2 Target Organism: Equus caballus (Horse) |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | QUADRISOL Approved UseReduction of inflammation and relief of pain associated with musculo-skeletal disorders and soft tissue lesions (traumatic injuries and surgical trauma). Launch Date1997 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
300000023674
Created by
admin on Fri Dec 15 16:59:23 GMT 2023 , Edited by admin on Fri Dec 15 16:59:23 GMT 2023
|
PRIMARY | |||
|
S154JX9N3H
Created by
admin on Fri Dec 15 16:59:23 GMT 2023 , Edited by admin on Fri Dec 15 16:59:23 GMT 2023
|
PRIMARY | |||
|
139033180
Created by
admin on Fri Dec 15 16:59:23 GMT 2023 , Edited by admin on Fri Dec 15 16:59:23 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
